Hauke G, Lührmann R, Metz B, Peter H H
Medizinische Universitätsklinik, Abt. Rheumatologie und Klinische Immunologie, Freiburg.
Z Rheumatol. 1988 Jan-Feb;47(1):26-9.
Detection of antibodies against extractable nuclear antigens (ENA) by counter immunoelectrophoresis (CIE) is currently used to screen sera from patients with collagen vascular disease. Although fast and reliable, the method has its limitations with regard to the differentiation of various antigen-antibody systems. In this study, results of the anti-ENA analysis by CIE and by Western-Blot technique are compared. Except for a higher frequency of Sm antibodies by Western-blot, the results of CIE were confirmed. The source of antigen and the higher sensitivity of the Western-Blot technique are responsible for the different results obtained. With respect to the relationship of antibody profile and illness, both methods demonstrated a high frequency of antibodies against U1-sn-RNP in mixed connective tissue disease and of anti-SS-B antibodies in Sjögren's syndrome.
目前采用对流免疫电泳(CIE)检测抗可提取核抗原(ENA)抗体,以筛选胶原血管病患者的血清。尽管该方法快速可靠,但在区分各种抗原-抗体系统方面存在局限性。在本研究中,对CIE法和蛋白质印迹法检测抗ENA的结果进行了比较。除蛋白质印迹法检测到的Sm抗体频率较高外,CIE的结果得到了证实。抗原来源和蛋白质印迹技术较高的灵敏度导致了不同的结果。关于抗体谱与疾病的关系,两种方法均显示混合性结缔组织病中抗U1-sn-RNP抗体以及干燥综合征中抗SS-B抗体的出现频率较高。